166 related articles for article (PubMed ID: 1505460)
1. Constitutive expression of osteoclast-stimulating activity by normal clonal osteoblast-like cells: effects of parathyroid hormone and 1,25-dihydroxyvitamin D3.
Collin P; Guenther HL; Fleisch H
Endocrinology; 1992 Sep; 131(3):1181-7. PubMed ID: 1505460
[TBL] [Abstract][Full Text] [Related]
2. Cloning of an osteoblastic cell line involved in the formation of osteoclast-like cells.
Yamashita T; Asano K; Takahashi N; Akatsu T; Udagawa N; Sasaki T; Martin TJ; Suda T
J Cell Physiol; 1990 Dec; 145(3):587-95. PubMed ID: 1703173
[TBL] [Abstract][Full Text] [Related]
3. Regulation of osteocalcin production and bone resorption by 1,25-dihydroxyvitamin D3 in mouse long bones: interaction with the bone-derived growth factors TGF-beta and IGF-I.
Staal A; Geertsma-Kleinekoort WM; Van Den Bemd GJ; Buurman CJ; Birkenhäger JC; Pols HA; Van Leeuwen JP
J Bone Miner Res; 1998 Jan; 13(1):36-43. PubMed ID: 9443788
[TBL] [Abstract][Full Text] [Related]
4. Effect of 24R,25-dihydroxyvitamin D3 on the formation and function of osteoclastic cells.
Yamato H; Okazaki R; Ishii T; Ogata E; Sato T; Kumegawa M; Akaogi K; Taniguchi N; Matsumoto T
Calcif Tissue Int; 1993 Mar; 52(3):255-60. PubMed ID: 8481842
[TBL] [Abstract][Full Text] [Related]
5. Induction of osteoclast characteristics in cultured avian blood monocytes; modulation by osteoblasts and 1,25-(OH)2 vitamin D3.
van't Hof RJ; Tuinenburg-Bol Raap AC; Nijweide PJ
Int J Exp Pathol; 1995 Jun; 76(3):205-14. PubMed ID: 7547432
[TBL] [Abstract][Full Text] [Related]
6. Involvement of dual signal transduction systems in the stimulation of osteoclast-like cell formation by parathyroid hormone and parathyroid hormone-related peptide.
Kaji H; Sugimoto T; Kanatani M; Fukase M; Chihara K
Biochem Biophys Res Commun; 1993 Jul; 194(1):157-62. PubMed ID: 8392835
[TBL] [Abstract][Full Text] [Related]
7. Heat-treated osteoblastic cell (ROS17/2.8)-conditioned medium induces the formation of osteoclast-like cells.
Kukita A; Kukita T; Hata K; Kurisu K; Kohashi O
Bone Miner; 1993 Nov; 23(2):113-27. PubMed ID: 8305877
[TBL] [Abstract][Full Text] [Related]
8. 1,25-Dihydroxyvitamin D3 stimulates rat osteoblastic cells to release a soluble factor that increases osteoclastic bone resorption.
McSheehy PM; Chambers TJ
J Clin Invest; 1987 Aug; 80(2):425-9. PubMed ID: 3611354
[TBL] [Abstract][Full Text] [Related]
9. Differential regulation of insulin-like growth factor-I (IGF-I) and IGF-II release from cultured neonatal mouse calvaria by parathyroid hormone, transforming growth factor-beta, and 1,25-dihydroxyvitamin D3.
Linkhart TA; Keffer MJ
Endocrinology; 1991 Mar; 128(3):1511-8. PubMed ID: 1999170
[TBL] [Abstract][Full Text] [Related]
10. Interaction between effects of parathyroid hormone and bisphosphonate on regulation of osteoclast activity by the osteoblast-like cell line UMR-106.
Yu X; Schøller J; Foged NT
Bone; 1996 Oct; 19(4):339-45. PubMed ID: 8894139
[TBL] [Abstract][Full Text] [Related]
11. Carboxyl-terminal parathyroid hormone fragments stimulate osteoclast-like cell formation and osteoclastic activity.
Kaji H; Sugimoto T; Kanatani M; Miyauchi A; Kimura T; Sakakibara S; Fukase M; Chihara K
Endocrinology; 1994 Apr; 134(4):1897-904. PubMed ID: 8137758
[TBL] [Abstract][Full Text] [Related]
12. Bisphosphonates induce osteoblasts to secrete an inhibitor of osteoclast-mediated resorption.
Vitté C; Fleisch H; Guenther HL
Endocrinology; 1996 Jun; 137(6):2324-33. PubMed ID: 8641182
[TBL] [Abstract][Full Text] [Related]
13. Stimulatory effect of bone morphogenetic protein-2 on osteoclast-like cell formation and bone-resorbing activity.
Kanatani M; Sugimoto T; Kaji H; Kobayashi T; Nishiyama K; Fukase M; Kumegawa M; Chihara K
J Bone Miner Res; 1995 Nov; 10(11):1681-90. PubMed ID: 8592944
[TBL] [Abstract][Full Text] [Related]
14. Effect of high phosphate concentration on osteoclast differentiation as well as bone-resorbing activity.
Kanatani M; Sugimoto T; Kano J; Kanzawa M; Chihara K
J Cell Physiol; 2003 Jul; 196(1):180-9. PubMed ID: 12767054
[TBL] [Abstract][Full Text] [Related]
15. Osteoclast-like cell formation and its regulation by osteotropic hormones in mouse bone marrow cultures.
Takahashi N; Yamana H; Yoshiki S; Roodman GD; Mundy GR; Jones SJ; Boyde A; Suda T
Endocrinology; 1988 Apr; 122(4):1373-82. PubMed ID: 3345718
[TBL] [Abstract][Full Text] [Related]
16. Osteoblastic cells mediate osteoclastic responsiveness to parathyroid hormone.
McSheehy PM; Chambers TJ
Endocrinology; 1986 Feb; 118(2):824-8. PubMed ID: 3455914
[TBL] [Abstract][Full Text] [Related]
17. Osteoblast-like cells in the presence of parathyroid hormone release soluble factor that stimulates osteoclastic bone resorption.
McSheehy PM; Chambers TJ
Endocrinology; 1986 Oct; 119(4):1654-9. PubMed ID: 3463505
[TBL] [Abstract][Full Text] [Related]
18. Activation of protease-activated receptor-2 leads to inhibition of osteoclast differentiation.
Smith R; Ransjö M; Tatarczuch L; Song SJ; Pagel C; Morrison JR; Pike RN; Mackie EJ
J Bone Miner Res; 2004 Mar; 19(3):507-16. PubMed ID: 15040840
[TBL] [Abstract][Full Text] [Related]
19. Synergistic effects of parathyroid hormone and 1,25-dihydroxyvitamin D3 on proliferation and vitamin D receptor expression of rat growth cartilage cells.
Klaus G; von Eichel B; May T; Hügel U; Mayer H; Ritz E; Mehls O
Endocrinology; 1994 Oct; 135(4):1307-15. PubMed ID: 7523093
[TBL] [Abstract][Full Text] [Related]
20. Microrough implant surface topographies increase osteogenesis by reducing osteoclast formation and activity.
Lossdörfer S; Schwartz Z; Wang L; Lohmann CH; Turner JD; Wieland M; Cochran DL; Boyan BD
J Biomed Mater Res A; 2004 Sep; 70(3):361-9. PubMed ID: 15293309
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
